Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Abuse Potential of Cenobamate in Recreational Drug Users
NCT03509285Phase 1Completed
- Sponsor
- SK Life Science, Inc.
- Start
- Mar 2017
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 1, randomised, double-blind trial of cenobamate in epilepsy (7 arms), sponsored by SK Life Science, Inc. Primary endpoint: Pharmacodynamics using Visual Analogue Scales (VAS) - Drug Liking at 24 hours. Started Mar 2017; status: completed.
02
Drugs
cenobamate
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT03509285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03509285.